GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Achieve Life Sciences Inc (NAS:ACHV) » Definitions » E10

Achieve Life Sciences (Achieve Life Sciences) E10 : $-705.08 (As of Mar. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Achieve Life Sciences E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Achieve Life Sciences's adjusted earnings per share data for the three months ended in Mar. 2024 was $-0.260. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-705.08 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average E10 Growth Rate was 24.90% per year. During the past 5 years, the average E10 Growth Rate was 19.10% per year. During the past 10 years, the average E10 Growth Rate was 23.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Achieve Life Sciences was 32.30% per year. The lowest was -10.20% per year. And the median was 14.70% per year.

As of today (2024-05-15), Achieve Life Sciences's current stock price is $5.01. Achieve Life Sciences's E10 for the quarter that ended in Mar. 2024 was $-705.08. Achieve Life Sciences's Shiller PE Ratio of today is .


Achieve Life Sciences E10 Historical Data

The historical data trend for Achieve Life Sciences's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Achieve Life Sciences E10 Chart

Achieve Life Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2,510.69 -2,065.14 -1,795.77 -1,449.21 -873.56

Achieve Life Sciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,342.64 -1,193.39 -1,007.25 -873.56 -705.08

Competitive Comparison of Achieve Life Sciences's E10

For the Biotechnology subindustry, Achieve Life Sciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Achieve Life Sciences's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Achieve Life Sciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Achieve Life Sciences's Shiller PE Ratio falls into.



Achieve Life Sciences E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Achieve Life Sciences's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.26/129.4194*129.4194
=-0.260

Current CPI (Mar. 2024) = 129.4194.

Achieve Life Sciences Quarterly Data

per share eps CPI Adj_EPS
201406 -1,034.000 100.560 -1,330.751
201409 -506.001 100.428 -652.074
201412 -572.001 99.070 -747.232
201503 -440.000 99.621 -571.611
201506 -572.001 100.684 -735.252
201509 -352.000 100.392 -453.780
201512 -132.000 99.792 -171.189
201603 -264.000 100.470 -340.068
201606 -506.001 101.688 -643.992
201609 -264.000 101.861 -335.425
201612 -418.000 101.863 -531.081
201703 -14.990 102.862 -18.860
201706 -12.132 103.349 -15.192
201709 -179.200 104.136 -222.709
201712 -62.606 104.011 -77.900
201803 -48.600 105.290 -59.738
201806 -36.400 106.317 -44.310
201809 -14.200 106.507 -17.255
201812 -11.000 105.998 -13.431
201903 -17.600 107.251 -21.238
201906 -10.080 108.070 -12.071
201909 -9.070 108.329 -10.836
201912 -6.000 108.420 -7.162
202003 -2.150 108.902 -2.555
202006 -1.680 108.767 -1.999
202009 -1.140 109.815 -1.344
202012 -0.773 109.897 -0.910
202103 -1.300 111.754 -1.505
202106 -1.530 114.631 -1.727
202109 -0.710 115.734 -0.794
202112 -0.760 117.630 -0.836
202203 -0.800 121.301 -0.854
202206 -1.080 125.017 -1.118
202209 -1.350 125.227 -1.395
202212 -0.830 125.222 -0.858
202303 -0.500 127.348 -0.508
202306 -0.430 128.729 -0.432
202309 -0.340 129.860 -0.339
202312 -0.240 129.419 -0.240
202403 -0.260 129.419 -0.260

Add all the adjusted EPS together and divide 10 will get our e10.


Achieve Life Sciences  (NAS:ACHV) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Achieve Life Sciences E10 Related Terms

Thank you for viewing the detailed overview of Achieve Life Sciences's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Achieve Life Sciences (Achieve Life Sciences) Business Description

Traded in Other Exchanges
Address
22722 29th Dr. SE, Suite 1000, Bothell, WA, USA, 98021
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the global smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for nicotine addiction.
Executives
John Bencich officer: CFO and PFO 2401 FOURTH AVENUE, SUITE 1050, SEATTLE WA 98121
Stuart Duty director 22722 29TH DR SE, SUITE 100, BOTHELL WA 98021
Thomas Sellig director 22722 29TH DR SE, SUITE 100, BOTHELL WA 98021
Thomas Braxton King director 91 JAMES AVENUE, ATHERTON CA 94027
Dialectic Life Sciences Spv Llc 10 percent owner C/O DIALECTIC LS MANAGER LLC, 119 ROWAYTON AVENUE, 2ND FLOOR, NORWALK CT 06853
Dialectic Ls Manager Llc 10 percent owner 119 ROWAYTON AVENUE, 2ND FLOOR, NORWALK CT 06853
John Fichthorn 10 percent owner C/O DIALECTIC CAPITAL MANAGEMENT, LLC, 17 STATE STREET, SUITE 3930, NEW YORK NY 10004
Dialectic Capital Management, Lp 10 percent owner 119 ROWAYTON AVENUE, 2ND FLOOR, NORWALK CT 06853
Dialectic Partners, Llc 10 percent owner 2ND FLOOR 119 ROWAYTON AVE, NORWALK CT 06853
Vaughn B Himes director C/O SEATTLE GENETICS, INC., 21823 30TH DRIVE SE, BOTHELL WA 98021
Financial Group Svb 10 percent owner 2270 SAND HILL ROAD, MENLO PARK CA 94025
Svb Innovation Credit Partners Viii, Llc 10 percent owner 2770 SAND HILL ROAD, MENLO CITY CA 94025
Svb Innovation Credit Fund Viii, L.p. 10 percent owner C/O SVB INNOVATION CREDIT PARTNERS VIII, 2770 SAND HILL ROAD, MENLO PARK CA 94025
Innovation Credit Fund Viii-a, L.p. 10 percent owner 2770 SAND HILL ROAD, MENLO PARK CA 94025
Svb Innovation Credit Partners Viii-a, Llc 10 percent owner 2770 SAND HILL ROAD, MENLO CITY CA 94025

Achieve Life Sciences (Achieve Life Sciences) Headlines